Governance & Oversight
Board &
Directorships
Strategic governance across leading pharmaceutical organizations, both domestic and international.
Strategic governance across leading pharmaceutical organizations, both domestic and international.
As a Director at Taro Pharmaceutical Industries Ltd., Sudhir V. Valia extends his governance expertise to the international stage. Taro, a multinational pharmaceutical company with significant operations in North America and Israel, benefits from his deep understanding of corporate finance, regulatory compliance, and strategic oversight.
His role on the Taro board involves contributing to strategic direction, reviewing financial performance, overseeing risk management frameworks, and ensuring alignment between corporate strategy and shareholder interests across diverse international markets.
Role: Director
Focus: Strategic direction, financial oversight, international governance
Markets: North America, Israel, International
Board-level strategic planning and direction
Financial performance review and oversight
Risk management and compliance frameworks
Stakeholder relations and corporate communications
Whole-Time Director
Executive leadership encompassing finance, operations, quality control, and strategic project management at one of the world's largest pharmaceutical companies.
Chief Financial Officer
Leading financial strategy for an innovative R&D-focused pharmaceutical company developing novel drug delivery systems and new chemical entities.
Director
International board governance, strategic oversight, and financial performance review for a multinational pharmaceutical company.
Sudhir V. Valia's approach to corporate governance is anchored in transparency, accountability, and long-term value creation. His board-level contributions reflect a commitment to the highest standards of corporate conduct and fiduciary responsibility.
Ensuring all corporate actions are transparent to stakeholders and that leadership remains accountable for performance and conduct.
Contributing to forward-looking strategic planning that positions organizations for sustainable growth in evolving markets.
Bringing financial expertise to bear on enterprise risk management, ensuring robust frameworks for identifying and mitigating strategic risks.
Balancing the interests of shareholders, employees, customers, and communities to create enduring organizational value.